KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,013,000 | -5.6% | 40,178 | -5.2% | 0.01% | 0.0% |
| Q2 2015 | $3,193,000 | +52.7% | 42,401 | +1.7% | 0.01% | +33.3% |
| Q1 2015 | $2,091,000 | +42.9% | 41,699 | -1.1% | 0.01% | +28.6% |
| Q4 2014 | $1,463,000 | +6.8% | 42,179 | +0.9% | 0.01% | -12.5% |
| Q3 2014 | $1,370,000 | -7.6% | 41,821 | +8.2% | 0.01% | -11.1% |
| Q2 2014 | $1,483,000 | +53.5% | 38,654 | +59.1% | 0.01% | +28.6% |
| Q1 2014 | $966,000 | +10.5% | 24,293 | +3.8% | 0.01% | 0.0% |
| Q4 2013 | $874,000 | – | 23,411 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |